Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Study of SGR-1505 in Mature B-Cell Neoplasms
Complete Title: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE
ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES
Trial Phase: I
Investigator: Ajay Gopal
The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) and/or recommended dose (RD) of SGR-1505.
Keywords:
- Lymphoma, Burkitt; Lymphoma; Lymphoma, Non-Hodgkin (NHL); Lymphoma, Marginal Zone; B-Cell Malignancies; Waldenstrom Macroglobulinemia; Lymphoma, Mantle-Cell; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Plasmablastic
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.